Apexigen, Inc.
APGN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$32,069 | -$28,916 | -$24,123 |
| Dep. & Amort. | $110 | $105 | $127 |
| Deferred Tax | $0 | $204 | $127 |
| Stock-Based Comp. | $1,883 | $1,143 | $1,345 |
| Change in WC | -$2,012 | $3,034 | $1,739 |
| Other Non-Cash | $1,395 | $528 | $828 |
| Operating Cash Flow | -$30,693 | -$23,902 | -$19,957 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$57 | -$54 | $0 |
| Net Acquisitions | $0 | $58,075 | $0 |
| Inv. Purchases | -$18,945 | -$20,179 | -$67,344 |
| Inv. Sales/Matur. | $29,957 | $42,257 | $43,183 |
| Other Inv. Act. | $0 | -$58,075 | $0 |
| Investing Cash Flow | $10,955 | $22,024 | -$24,161 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $0 |
| Stock Issued | $20,594 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $11,097 | $37 | $12,897 |
| Financing Cash Flow | $11,097 | $37 | $12,897 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | -$8,641 | -$1,841 | -$31,221 |
| Supplemental Information | – | – | – |
| Beg. Cash | $23,443 | $25,284 | $56,505 |
| End Cash | $14,802 | $23,443 | $25,284 |
| Free Cash Flow | -$30,750 | -$23,956 | -$19,957 |